Efficacy and safety of glatiramer acetate in multiple sclerosis patients with allergic respiratory diseases

被引：0
|
作者：
Mallucci, G.
La Mantia, L.
Confalonieri, P. A.
Galgani, S.
Haggiag, S.
Lugaresi, A.
De Luca, G.
Solaro, C.
Trabucco, E.
Meola, G.
Robotti, M.
Cavaletti, G.
Frigeni, B.
Clerici, R.
Chiveri, L.
Bono, G.
Banfi, P.
Ambrosoni, E.
Mancardi, L.
Della Cava, F.
Balgera, R.
Bergamaschi, R.
机构：
[1] Fdn Ist Neurol Nazl C Mondino IRCCS, Pavia, Italy
[2] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[3] Azienda Osped San Camillo Forlanini, Rome, Italy
[4] Policlin SS Annunziata, Chieti, Italy
[5] ASL3 Genovese, Genoa, Italy
[6] IRCCS Policlin San Donato, Milan, Italy
[7] Azienda Osped San Gerardo, Monza, Italy
[8] Osped Valduce, Como, Italy
[9] Osped Circolo Varese, Varese, Italy
[10] Fdn Macchi, Varese, Italy
[11] IRCCS Azienda Osped Univ San Martino, Genoa, Italy
[12] Azienda Osped Prov Lecco, Lecce, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：428 / 429
页数：2
相关论文
共 50 条
  • [31] The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment
    Messina, Silvia
    Patti, Francesco
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (10) : 1349 - 1359
  • [32] Economic impact of glatiramer acetate in multiple sclerosis
    Ollendorf, DA
    Jilinskaia, E
    Oleen-Burkey, M
    VALUE IN HEALTH, 2002, 5 (06) : 510 - 511
  • [33] Glatiramer acetate: Mechanisms of action in multiple sclerosis
    Schrempf, Wiebke
    Ziemssen, Tjalf
    AUTOIMMUNITY REVIEWS, 2007, 6 (07) : 469 - 475
  • [34] Glatiramer acetate therapy for multiple sclerosis: a review
    Perumal, Jai
    Filippi, Massimo
    Ford, Corey
    Johnson, Kenneth
    Lisak, Robert
    Metz, Luanne
    Tselis, Alexandros
    Tullman, Mark
    Khan, Omar
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (06) : 1019 - 1029
  • [35] Sublingual Immunotherapy for Allergic Respiratory Diseases: Efficacy and Safety
    Passalacqua, Giovanni
    Canonica, Giorgio Walter
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2011, 31 (02) : 265 - +
  • [36] Mechanisms of action of glatiramer acetate in multiple sclerosis
    Neuhaus, O
    Farina, C
    Wekerle, H
    Hohlfeld, R
    NEUROLOGY, 2001, 56 (06) : 702 - 708
  • [37] Effects of glatiramer acetate therapy on metabolic markers in multiple sclerosis patients
    Montella, S.
    Petracca, M.
    Matarese, G.
    Carbone, F.
    La Rocca, C.
    Carrieri, P.
    JOURNAL OF NEUROLOGY, 2011, 258 : 206 - 207
  • [38] Effects of interferon and glatiramer acetate on cytokine patterns in multiple sclerosis patients
    Ganji, Ali
    Monfared, Mohsen Ebrahimi
    Shapoori, Shima
    Nourbakhsh, Parisa
    Ghazavi, Ali
    Ghasami, Keyvan
    Mosayebi, Ghasem
    CYTOKINE, 2020, 126
  • [39] Treatment with glatiramer acetate (Copaxone®) prevents neurodegeneration in patients with multiple sclerosis
    Jaworski, J.
    Leinhard, O. Dahlqvist
    Tisell, A.
    Lundberg, P.
    Landtblom, A. M.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S140 - S141
  • [40] Pregnancy outcomes in patients with multiple sclerosis and exposure to branded glatiramer acetate
    Qassem, Shahd
    Melamed-Gal, Sigal
    Baruch, Peleg
    NEUROLOGY, 2019, 92 (15)
12345